What do you mean "who care", you made the incorrect statement so don't you care??? Like I told you, both stocks are in a totally different market and regulatory are more strict on NDA as they should be than whatever product TRP is selling, that's why it cost $10o of millions and even billions for the kind of Ph3 clinical trials. And like I told you, clearly PH wants all the IP at a development stage to sell the entire company, this is when IMU will get maximum return for IMU
IMUGENE CHART. TA only, page-33820
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.1¢ |
Change
-0.001(1.92%) |
Mkt cap ! $374.8M | |||
| Open | High | Low | Value | Volume |
| 5.1¢ | 5.3¢ | 5.0¢ | $983.7K | 19.10M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 492446 | 5.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.2¢ | 382941 | 3 |
View Market Depth
| Last trade - 16.10pm 05/08/2024 (20 minute delay) ? |
| IMU (ASX) Chart |